Efficacy and Safety of Ruxolitinib in Patients With Myelofibrosis

NCT05410470 · clinicaltrials.gov ↗

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: Ruxolitinib

Sponsor

Qilu Hospital of Shandong University